from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2895c/viuB

LFCtreatmentdescriptionclass of inhibitor

-0.710

Amikacinug/mL Amikacintranslation

-1.512

Cap5-10ug/mL Capreomycintranslation

-1.377

Rox10-50 ug/mL Roxithromycintranslation

-0.492

SM2-5 ug/mL Streptomycintranslation

-1.792

Tet5-10 ug/mL Tetracyclinetranslation

2.025

Rif0.2-5ug/mL Rifampicintranscription

1.284

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.662

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.146

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.586

CPZ10-50 ug/mL Chlorpromazinerespiration

1.095

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.128

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.669

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.271

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.209

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.020

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.359

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.022

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.225

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.550

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.730

KCN5-20 ug/mL Potassium cyaniderespiration

0.380

NaN30.2-2 mM Sodium aziderespiration

-1.019

Nigericin50 uM Nigericinrespiration

0.093

TRC10-150 ug/mL Triclosanrespiration

0.853

TRZ10-25 ug/mL Thioridazinerespiration

-0.600

Valinomycin0.5-10 uM Valinomycinrespiration

0.140

ZnSO42 mM ZnSO4respiration

0.756

menadione6-10 ug/mL Menadionerespiration

0.202

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.809

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.007

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.466

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.140

NRP_1Non-replicating persistence stage 1dosRassociated

-0.008

Amp0.2mg/mL AmpicillincellWall

-0.099

Cephalexin20-100 ug/mL CephalexincellWall

-0.510

Cerulenin0.32-5 ug/mL CerulenincellWall

1.254

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.593

EMB10-20 ug/mL EthambutolcellWall

-0.627

Eta12-40 ug/mL EthionamidecellWall

-0.943

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.143

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.124

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.218

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.491

BZA0.12 mg/mL BenzamidearomaticAmides

-0.015

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.584

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.144

H2O24 mM hydrogen peroxideDNAdamaging

-0.139

Levo10 ug/mL LevofloxacinDNAdamaging

-0.564

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.147

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.292

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.337

UVUV-irradiationDNAdamaging

0.133

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.131

Antimycin12.5-50 ug/mL Antimycin A?

0.355

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.383

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.539

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.277

PA8240.2-2 ug/mL PA-824?

-0.774

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.251

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.502

Verapamil50 uM Verapamil?

0.582

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.216

methoxatin10-20 ug/mL Methoxatin?